Alejandro C. Balsa

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications

Correction: Unilateral diffuse alveolar hemorrhage in granulomatosis with polyangiitis.

Correction: Unilateral diffuse alveolar hemorrhage in granulomatosis with polyangiitis.

Journal: Clinical rheumatology
Published: August 14, 2026

Treatment of rheumatoid arthritis-associated interstitial lung disease: What is new since the 2022 SER-SEPAR recommendations?

Treatment of rheumatoid arthritis-associated interstitial lung disease: What is new since the 2022 SER-SEPAR recommendations?

Journal: Reumatologia clinica
Published: October 03, 2025

Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis.

Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis.

Journal: Frontiers in immunology
Published: May 27, 2025

Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA.

Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA.

Journal: Biomedicines
Published: March 17, 2025

Can we identify axial spondyloarthritis among young adults referred to non-rheumatology specialists? Results from the SHERPAS study.

Can we identify axial spondyloarthritis among young adults referred to non-rheumatology specialists? Results from the SHERPAS study.

Journal: Seminars in arthritis and rheumatism
Published: March 15, 2025

Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?

Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?

Journal: Nutrients
Published: February 04, 2025

Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold.

Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold.

Journal: Arthritis research & therapy
Published: January 30, 2025

Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study.

Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study.

Journal: The Journal of rheumatology
Published: December 12, 2024

Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology.

Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology.

Journal: Reumatologia clinica
Published: November 19, 2024

Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary.

Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary.

Journal: Rheumatology and therapy
Published: August 05, 2024

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients.

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients.

Journal: Frontiers in medicine
Published: July 08, 2024

Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.

Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.

Journal: Clinical rheumatology
Published: June 17, 2024
Showing 1-12 of 185

Last Updated: 09/26/2026